ArticleJTO clinical and research reports2022

Heterogeneous Outcomes of Immune Checkpoint Inhibitor Rechallenge in Patients With NSCLC: A Systematic Review and Meta-Analysis.

Shiting Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.